Clinical Trials

Showing trials with last updates posted in 2025.

NCT05939700 | RECRUITING
20 participants

Mavacamten Pregnancy Surveillance Program

Study Type:
OBSERVATIONAL
Last Updated:
2025-11-06
Start Date:
2023-11-09
Completion:
2027-04-30
Conditions
  • Breastfeeding
  • Hypertrophic Cardiomyopathy
  • Pregnancy Related
Interventions
  • DRUG
No Results Yet
NCT05252390 | TERMINATED | PHASE1
82 participants

NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-06
Start Date:
2022-03-29
Completion:
2024-07-15
Conditions
  • Advanced Solid Tumor
  • Ovarian Cancer
  • Ovary Cancer
  • Cancer of Ovary
  • Cancer of the Ovary
  • Ovary Neoplasm
  • Pancreatic Cancer
  • Pancreas Cancer
  • Cancer of Pancreas
  • Cancer of the Pancreas
  • Pancreas Neoplasm
  • Prostate Cancer
  • Prostatic Cancer
  • Cancer of Prostate
  • Cancer of the Prostate
  • Prostate Neoplasm
  • Castrate Resistant Prostate Cancer
  • Castration Resistant Prostatic Cancer
  • Castration Resistant Prostatic Neoplasms
  • Triple-negative Breast Cancer
  • Triple Negative Breast Cancer
  • Triple Negative Breast Neoplasms
  • Breast Cancer
  • Breast Carcinoma
  • Cancer of Breast
  • Cancer of the Breast
  • Breast Tumor
Interventions
  • DRUG
No Results Yet
NCT05245903 | RECRUITING
40 participants

Passive Sensor Identification of Digital Biomarkers to Assess Effects of Orally Administered Nicotinamide Riboside

Study Type:
OBSERVATIONAL
Last Updated:
2025-11-06
Start Date:
2022-05-31
Completion:
2026-05-31
Conditions
  • Alzheimer Disease
  • Dementia Alzheimers
  • Dementia
  • Cognitive Impairment
  • Mild Cognitive Impairment
  • Neurodegenerative Diseases
  • Neurocognitive Disorders
  • Neurocognitive Dysfunction
  • Cognitive Dysfunction
  • Mental Disorder
Interventions
  • DEVICE
No Results Yet
NCT04742439 | WITHDRAWN | NA
0 participants

Individualizing tDCS Dose

Study Type:
INTERVENTIONAL
Last Updated:
2025-11-06
Start Date:
2024-12-02
Completion:
2024-12-02
Conditions
  • tDCS
  • Motor Function
Interventions
  • DEVICE
No Results Yet
NCT04729062 | APPROVED_FOR_MARKETING

C3G/Primary IC-MPGN EAP

Study Type:
EXPANDED_ACCESS
Last Updated:
2025-11-06
Conditions
  • C3G
  • IC-MPGN
  • C3 Glomerulopathy
  • C3 Glomerulonephritis
  • Complement 3 Glomerulopathy
  • Complement 3 Glomerulopathy (C3G)
  • Complement 3 Glomerulonephritis
  • Dense Deposit Disease
  • DDD
  • Membranoproliferative Glomerulonephritis
  • Membranoproliferative Glomerulonephritis (MPGN)
  • Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page